Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Steven O'Reilly.

Newcastle AuthorsTitleYearFull text
Sadaf Atarod
Jean Norden
Louis Bibby
Dr Clare Lendrem
Dr Kim Pearce
et al.
Differential MicroRNA Expression Levels in Cutaneous Acute Graft-versus-Host Disease2018
Dr Marzena Ciechomska
Dr Steven O'Reilly
Professor Fiona Oakley
Professor Jaap van Laar
Histone Demethylation and Toll-like Receptor 8-Dependent Cross-Talk in Monocytes Promotes Transdifferentiation of Fibroblasts in Systemic Sclerosis Via Fra-22016
Dr Steven O'Reilly
Pound the alarm: danger signals in rheumatic diseases2015
Dr Marzena Ciechomska
Dr Steven O'Reilly
Professor Jaap van Laar
A novel role of MIR-29a in inhibition of TAB1-mediated timp-1 production in dermal fibroblasts: implication for SSC pathogenesis2014
Dr Marzena Ciechomska
Professor Jaap van Laar
Dr Steven O'Reilly
Emerging role of epigenetics in systemic sclerosis pathogenesis2014
Dr Steven O'Reilly
Innate immunity in systemic sclerosis pathogenesis2014
Dr Steven O'Reilly
Dr Marzena Ciechomska
Rachel Cant
Professor Jaap van Laar
Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-beta (TGF-beta) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein2014
Dr Steven O'Reilly
Rachel Cant
Dr Marzena Ciechomska
Professor Fiona Oakley
Professor Sophie Hambleton
et al.
Serum Amyloid A (SAA) induces IL-6 in dermal fibroblasts via TLR2, IRAK4 and NF-κB2014
Dr Steven O'Reilly
Rachel Cant
Dr Marzena Ciechomska
James Finnigan
Professor Fiona Oakley
et al.
Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-kappa B2014
Dr Lindsay Murphy
Dr Saimir Luli
Dr Lee Borthwick
Dr Steven O'Reilly
Professor Neil Perkins
et al.
Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune response2013
Dr Steven O'Reilly
Rachel Cant
Dr Marzena Ciechomska
Professor Jaap Van Laar
Interleukin-6: a new therapeutic target in systemic sclerosis?2013
Dr Catherine Stroud
Dr Mario Abinun
Dr Steven O'Reilly
Dr Marzena Ciechomska
Dr Stephen Owens
et al.
Late Onset Invasive Pneumococcal Disease in a Patient with IRAK4 Deficiency2013
Dr Steven O'Reilly
Role of interleukin-13 in fibrosis, particularly systemic sclerosis2013
Dr Marzena Ciechomska
Rachel Cant
James Finnigan
Professor Jaap Van Laar
Dr Steven O'Reilly
et al.
Role of toll-like receptors in systemic sclerosis2013
Dr Nicola Fullard
Dr Steven O'Reilly
Professor Jaap Van Laar
David Faini
Julie Diboll
et al.
The c-Rel Subunit of NF-κB Regulates Epidermal Homeostasis and Promotes Skin Fibrosis in Mice2013
Dr Thomas Huegle
Dr Steven O'Reilly
Rachel Simpson
Dr Venetia Bigley
Professor Matthew Collin
et al.
Tumor Necrosis Factor-Costimulated T Lymphocytes From Patients With Systemic Sclerosis Trigger Collagen Production in Fibroblasts2013
Dr Marzena Ciechomska
Christiaan Huigens
Dr Andreas Gessner
Dr Steven O'Reilly
Professor Jaap Van Laar
et al.
A novel role of monocytes in the induction of profibrotic tissue-inhibitor of metalloproteinase-1 mediated by toll-like receptors stimulation in SSC2012
Nadine Binai
Dr Steven O'Reilly
Dr Bridget Griffiths
Professor Jaap Van Laar
Differentiation Potential of CD14(+) Monocytes into Myofibroblasts in Patients with Systemic Sclerosis2012
Dr Steven O'Reilly
Dr Marzena Ciechomska
Professor Jaap Van Laar
Interleukin-6, its role in fibrosing conditions2012
Dr Steven O'Reilly
Dr Bridget Griffiths
Dr Anja Krippner-Heidenreich
Professor Jaap Van Laar
T cell derived IL-6 and IL-13 drive fibroblast fibrosis: Implications for systemic sclerosis2012
Dr Steven O'Reilly
Professor Jaap Van Laar
T cells in systemic sclerosis: a reappraisal2012
Dr Marzena Ciechomska
Dr Steven O'Reilly
TOLL-LIKE RECEPTOR-MEDIATED EXPRESSION OF PROFIBROTIC MEDIATORS BY CIRCULATING MONOCYTES IN SYSTEMIC SCLEROSIS2012
Dr Marzena Ciechomska
Dr Andreas Gessner
Dr Steven O'Reilly
Professor Jaap Van Laar
Toll-like receptor-mediated expression of profibrotic tissue-inhibitor of metalloproteinase-1 by circulating monocytes in Systemic sclerosis2012
Dr Steven O'Reilly
Dr Venetia Bigley
Professor Matthew Collin
Dr Anja Krippner-Heidenreich
Professor Jaap van Laar
et al.
Tumor necrosis factor-alpha co-activated T-cells support a profibrotic cytokine milieu on cost of IL-10 expression in patients with systemic sclerosis2012
Dr Steven O'Reilly
Inducers of Cross-Linked Actin Networks (CLANs) in Trabecular Meshwork Cells2011
Dr Steven O'Reilly
Dr Thomas Huegle
Dr Anja Krippner-Heidenreich
Professor Jaap Van Laar
T cell-derived IL-6 and IL-13 drive dermal fibrosis: implications for systemic sclerosis2011
Dr Thomas Huegle
Dr Anja Krippner-Heidenreich
Rachel Simpson
Dr Steven O'Reilly
Dr Venetia Bigley
et al.
Tumour necrosis factor alpha receptor activated T cells of patients with systemic sclerosis are deficient in IL-10 expression but promote myofibroblast differentiation via IL-6 and TGF-beta2011
Dr Steven O'Reilly
Cross-Linked Actin Networks (CLANs) are presnet in lamina cribrosa cells2010
Dr Steven O'Reilly
Cross-Linked Actin Networks (CLANs) in bovine trabecular meshwork cells2009
Dr Mark Verrill
Dr Steven O'Reilly
TEXAS (Taxotere (R) EXperience with Anthracyclines Study) trial: mature results of activity/toxicity of docetaxel given with anthracyclines in a community setting, as first line therapy for MBC2007
Wei Zhang
Dr Fraser Birrell
Christopher McCarthy
Dr Steven O'Reilly
Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee - The MOVE concensus2005